Mauritania vs Sur: Previously treated cases tested for RR-/MDR-TB
Mauritania
100.0%
in 2023
Sur
62.0%
in 2024
Mauritania rank
1st
Sur rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Mauritania
- Sur
How they compare
Mauritania currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Mauritania's figure about 1.6 times Sur's.
The two have swapped places 5 times across 12 shared years of data; in 2005 it was Mauritania ahead.
Mauritania ranks 1st and Sur ranks 1st of 180 countries.
Across the 3 decades both report, Mauritania averaged higher in 1 and Sur in 2.
Head to head by decade
| Decade | Mauritania | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 9.1% | 21.5% | 12.4% | Sur |
| 2010s | 44.7% | 62.3% | 17.6% | Sur |
| 2020s | 100.0% | 82.5% | 17.5% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mauritania or Sur?
- Mauritania, at 100.0% against 62.0% in Sur as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mauritania and Sur?
- 38.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Sur?
- 12 years are reported by both, from 2005 to 2023.
- How do Mauritania and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Mauritania ranks 1st and Sur ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.